Pyridostigmine Bromide

溴吡斯的明

Report date: 2025/07/29 10:38:32
NME

Base Information

Drug NamePyridostigmine Bromide
Drug Alias Namebromuro de piridostigmina溴化3-二甲氨基甲酰氧基-1-甲基吡啶美斯的侬bromure de pyridostigminepyridostigmini bromidum +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)PoisoningConstipation +[20] 
Global Approved IndicationsLambert-Eaton Myasthenic Syndrome
Approved Indications in ChinaLambert-Eaton Myasthenic Syndrome
Original Approved Country/TerritoryUnited States
Original Approved Date1955/04/06
Country/TerritoryUnited StatesMexicoMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's HospitalAlvogen IncIcahn School Of Medicine At Mount Sinai +[7] 
Inactive CompaniesInstituto Nacional De Ciencias Medicas Y Nutricion Salvador ZubiranOregon Health And Science UniversityUniversitair Ziekenhuis Brussel +[10] 
Active IndicationsConstipationDyskinesiasParkinson Disease +[11] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)PoisoningImmunologic Deficiency Syndromes +[9] 

Other Information

ATC CodeN07AA02
Related LinksWikipediaDrugBankKEGG